Part I: Hodgkin's lymphoma—molecular biology of Hodgkin and Reed-Sternberg cells
- 1 January 2004
- journal article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 5 (1), 11-18
- https://doi.org/10.1016/s1470-2045(03)01319-6
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin–Reed-Sternberg cellsOncogene, 2002
- Functional expression of receptor activator of nuclear factor κB in Hodgkin disease cell linesBlood, 2001
- Deregulation of immunoglobulin gene transcription in the Hodgkin-Reed Sternberg cell line L1236British Journal of Haematology, 2001
- Analysis of BCL-6 mutations in classic Hodgkin disease of the B- and T-cell typeBlood, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Detection of Epstein-Barr Virus in Hodgkin-Reed-Sternberg Cells: No Evidence for the Persistence of Integrated Viral Fragments in Latent Membrane Protein-1 (LMP-1)-Negative Classical Hodgkin's DiseaseThe American Journal of Pathology, 2000
- The Hallmarks of CancerCell, 2000
- Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.JCI Insight, 1997
- Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2.The Journal of Experimental Medicine, 1996
- Hodgkin's Disease and Epstein-Barr VirusNew England Journal of Medicine, 1989